Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Preoperative, Proton- Radiotherapy Combined With Chemotherapy for Borderline Resectable Pancreatic Cancer [NA]
A clinical trial evaluating preoperative proton radiotherapy combined with chemotherapy for borderline resectable pancreatic cancer; the stu…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs
A Pan-European post-authorization safety study evaluating whether initiating exenatide in type 2 diabetes patients is associated with a diff…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Cholesterol Disruption in Combination With the Standard of Care in Patients With Advanced Pancreatic Adenocarcinoma [EARLY_Phase 1]
An early-phase trial evaluating cholesterol-disruption in combination with standard of care for advanced pancreatic ductal adenocarcinoma; t…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies [Phase 1]
Phase 1 clinical trial evaluating RSC-1255 in patients with advanced malignancies carrying RAS mutations, sponsored by RasCal Therapeutics, …
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Resilience and Equity in Aging, Cancer, and Health (REACH) [NA]
The REACH trial sponsored by Dana-Farber Cancer Institute is currently recruiting. It targets multiple gastrointestinal cancers including ga…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 clinical trial update for FMC-376 in KRAS G12C-mutated solid tumors, currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Tumour Regulatory Molecules in Early Pancreatic Cancer Detection
An ongoing clinical trial, sponsored by Hull University Teaching Hospitals NHS Trust, is investigating tumour regulatory molecules for early…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Impact of Hypertrophy-oriented Resistance Training on Muscle Mass and Quality of Life in Patients With Unresectable Pancreatic Cancer [NA]
This clinical trial update describes a study evaluating whether hypertrophy-oriented resistance training can improve muscle mass and quality…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Access to Genetic Testing in Underserved Patients With Cancer [NA]
This entry reports on a clinical trial investigating access to genetic testing for cancer patients in underserved populations, with recruitm…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Early Phase Study of KESONOTIDE™in Participants With Solid Tumours [Phase 1, Phase 2]
KESONOTIDE is being studied in an early-phase (Phase 1/Phase 2) trial for solid tumours and is currently recruiting across multiple cancer i…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Identification of Biomarkers Associated With the Presence of Malignant Pancreatic Lesions Compared to Benign Lesions. [NA]
The study aims to identify biomarkers that distinguish malignant pancreatic lesions from benign pancreatic lesions.
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Stereotactic Adaptive Radiation Therapy of Borderline Resectable Pancreatic Cancer an Individualized Approach [NA]
Ongoing recruitment for a clinical trial evaluating stereotactic adaptive radiation therapy for border-line resectable pancreatic cancer, sp…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Feasibility Study to Investigate Rectal Mucus in Aero-Digestive Tract Cancer.
A feasibility study sponsored by Origin Sciences is recruiting to investigate rectal mucus in aero-digestive tract cancers, including Non-Sm…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: A Study of Suizenji in Patients With Unresectable Pancreatic Cancer [NA]
Clinical trial update for Suizenji in patients with unresectable pancreatic cancer; the study is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Study of EGFRBi Armed Fresh PBMC in Metastatic or Unresectable Pancreatic Cancer [Phase 1, Phase 2]
This is a clinical trial update for a phase 1/2 study evaluating EGFRBi armed fresh PBMC in patients with metastatic or unresectable pancrea…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Surufatinib Plus mFOLFIRINOX and PD-1 Inhibitor as the Neoadjuvant Therapy for High-risk or Borderline Resectable Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating neoadjuvant therapy for high-risk or borderline resectable pancreatic cancer using surufatinib plus mFOLFIRINOX and…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: GATA6 Expression as a Predictor of Response to Peri-Operative Chemotherapy in Resectable Pancreatic Adenocarcinoma [NA]
The study investigates whether GATA6 expression can predict response to peri-operative chemotherapy in resectable pancreatic cancer, with th…
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: Phase I Trial of Defactinib and VS-6766. [Phase 1]
A Phase I clinical trial evaluating the combination of defactinib and VS-6766 across multiple solid tumors, including non-small cell lung ca…
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: A Prospective Registry for Patients at High-Risk for Pancreatic Cancer
A Mayo Clinic-sponsored prospective registry for individuals at high risk of pancreatic cancer, including pancreatic ductal adenocarcinoma, …
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: Research of the Application of Pancreatic Cancer Screening Artificial Intelligence Model "PANDAPro" [NA]
An ongoing clinical trial from Zhejiang University evaluating PANDAPro, an AI-based pancreatic cancer screening model, in participants to as…
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: Clinical Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of LM-108 ± Penpulimab+Chemotherapy in Advanced Solid Tumors - Cohort C [Phase 1, Phase 2]
This clinical trial update describes a Phase 1/2 study evaluating LM-108 with Penpulimab and chemotherapy in patients with advanced pancreat…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Feasibility Study: IGNITE-TX (Identifying Individuals for Genetic Testing & Treatment) Intervention [NA]
The study IGNITE-TX is a feasibility trial from MD Anderson Cancer Center to identify individuals for genetic testing and treatment across m…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders
A Mayo Clinic-sponsored clinical trial update recruiting to collect medical information and tissue samples from patients with pancreatic can…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Pancreatic Cancer [EARLY_Phase 1]
Pilot Phase 1 study evaluating an implantable microdevice to assess in situ drug response in pancreatic cancer patients. The study is curren…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Collecting Blood and Tissue Samples From Family Members of Patients With Pancreatic Diseases, Pancreatic Cancer, and Melanoma
Mayo Clinic is conducting a study to collect blood and tissue samples from family members of patients with pancreatic diseases, pancreatic c…